AbbVie Inc. Annual Depreciation in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
AbbVie Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2024.
  • AbbVie Inc. Depreciation for the quarter ending December 31, 2024 was $206M, a 10.2% increase year-over-year.
  • AbbVie Inc. Depreciation for the twelve months ending December 31, 2024 was $764M, a 1.6% increase year-over-year.
  • AbbVie Inc. annual Depreciation for 2024 was $764M, a 1.6% increase from 2023.
  • AbbVie Inc. annual Depreciation for 2023 was $752M, a 3.34% decline from 2022.
  • AbbVie Inc. annual Depreciation for 2022 was $778M, a 3.11% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $764M +$12M +1.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 $752M -$26M -3.34% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
2022 $778M -$25M -3.11% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-14
2021 $803M +$137M +20.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $666M +$202M +43.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $464M -$7M -1.49% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $471M +$46M +10.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $425M $0 0% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $425M +$8M +1.92% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $417M +$34M +8.88% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $383M -$5M -1.29% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $388M -$137M -26.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $525M +$17M +3.35% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-20
2011 $508M Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.